quinazolines has been researched along with Cirrhosis, Liver in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (33.33) | 18.7374 |
1990's | 1 (3.33) | 18.2507 |
2000's | 8 (26.67) | 29.6817 |
2010's | 8 (26.67) | 24.3611 |
2020's | 3 (10.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, S; Li, J; Luo, H; Mo, M; Sun, B; Xu, B; Yang, H; Yang, L; Yu, J; Zhang, A | 1 |
Hwang, JS; Jang, BK; Kang, YN; Kim, MK; Lee, JH; Lee, SH; Park, KG; Seo, HY | 1 |
Deng, YG; Li, GF; Liu, SJ; Lyu, XL; Zhang, SC; Zhao, BX; Zhu, YL | 1 |
Ishikawa, T; Nakamura, M; Nishiyama, R; Saito, SY; Todoroki, K; Toyo'oka, T; Yamaguchi, M | 1 |
Heikkilä, P; Jalanko, H; Kerola, A; Lampela, H; Lohi, J; Mutanen, A; Pakarinen, MP | 1 |
Chen, H; Hu, J; Liang, D; Liang, G; Liu, Z; Wang, J; Wang, W; Zhang, W; Zhao, L; Zhong, P | 1 |
Han, J; Jiang, L; Jin, Z; Lou, D; Qian, Y; Xu, J; Yang, Y; Yu, Q; Zhou, L | 1 |
Bardeesy, N; Caravan, P; Chen, X; Crenshaw, A; DePeralta, DK; Fuchs, BC; Fujii, T; Golub, TR; Gupta, S; Hoshida, Y; Kuroda, T; Lanuti, M; Lauwers, GY; McGinn, CM; Onofrio, R; Schmitt, AD; Tanabe, KK; Taylor, B; Wei, L; Winckler, W; Yamada, S | 1 |
Dong, JZ; Lu, MQ; Wang, LP; Zhang, SN; Zou, ZL | 1 |
Fuchs, BC; Hoshida, Y; Tanabe, KK | 1 |
Byrjalsen, I; Christiansen, C; Gardner, S; Goodman, Z; Henriksen, K; Karsdal, MA; Krag, A; Leeming, DJ; Nielsen, MJ; Patel, K; Schuppan, D | 1 |
Kim, YH; Mio, T; Mishima, M | 1 |
Alexiev, R; Anbinder, N; Genina, O; Mawasi, N; Paizi, M; Pines, M; Spira, G | 1 |
Hanajiri, K; Maruyama, T; Mitsui, H; Nakajima, J; Omata, M | 1 |
BRAILOVSKY, D; ESTEVEZ, E; FERNANDEZ, E; ROMERO, T | 1 |
DATEY, KK; PANDYA, VN | 1 |
GRIFFIN, R; STEIGMANN, F | 1 |
BRENES, C; FARRERASVALENTI, P; ROZMAN, C | 1 |
COOKE, AR | 1 |
Barbu, V; Cacheux, W; Clergue, F; Desbois-Mouthon, C; Housset, C; Poupon, R; Rey, C; Rosmorduc, O; Schiffer, E; Wendum, D | 1 |
Bauer, M; Niedobitek, E; Patsenker, E; Popov, Y; Schulze-Krebs, A; Schuppan, D | 1 |
Antonaci, S; Giannelli, G | 1 |
Carter, DC; Farah, DA; Lorimer, AR; Mills, PR; Rae, AP; Russell, RI | 1 |
Blaschke, T; Rubin, P | 1 |
Nagler, A; Pines, M | 1 |
Aeed, H; Alexiev, R; Avni, Y; Bruck, R; Genina, O; Nagler, A; Pines, M | 1 |
Artigue, F; Buffet, C; Cassan, P; Flamenbaum, M; Garcia, V; Kemeny, JL | 1 |
Buamah, PK; Harris, AL; James, OF; Skillen, AW | 1 |
Itoh, T; Kambayashi, J; Mori, T; Sakon, M; Tsujinaka, T; Uemura, Y | 1 |
Lowenthal, DT; Shear, L | 1 |
2 review(s) available for quinazolines and Cirrhosis, Liver
Article | Year |
---|---|
Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice.
Topics: Antineoplastic Agents; beta Catenin; Carcinoma, Hepatocellular; Cell Differentiation; Cell Transformation, Neoplastic; ErbB Receptors; Gefitinib; Humans; Liver Cirrhosis; Neoplasm Invasiveness; Prognosis; Quinazolines | 2006 |
Halofuginone: a novel antifibrotic therapy.
Topics: Animals; Collagen; Fibrosis; Humans; Liver Cirrhosis; Piperidines; Postoperative Complications; Protein Synthesis Inhibitors; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Skin; Tissue Adhesions | 1998 |
2 trial(s) available for quinazolines and Cirrhosis, Liver
Article | Year |
---|---|
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.
Topics: Biomarkers; Collagen Type III; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Oxazoles; Patient Selection; Quinazolines; Thiazolidinediones; Tyrosine | 2016 |
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Portal Vein; Prazosin; Propranolol; Quinazolines | 1984 |
26 other study(ies) available for quinazolines and Cirrhosis, Liver
Article | Year |
---|---|
A Novel Quinazoline Derivative Prevents and Treats Arsenic-Induced Liver Injury by Regulating the Expression of RecQ Family Helicase.
Topics: Animals; Arsenic; Arsenites; Chemical and Drug Induced Liver Injury, Chronic; Liver; Liver Cirrhosis; Mice; Molecular Docking Simulation; Oxidative Stress; Quinazolines; RecQ Helicases | 2023 |
Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connetive Tissue Growth Factor.
Topics: Animals; Autophagy; Benzodioxoles; Cells, Cultured; Connective Tissue Growth Factor; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Mice, Inbred C57BL; Phosphorylation; Quinazolines; src-Family Kinases; STAT3 Transcription Factor; Thioacetamide; Transforming Growth Factor beta; Up-Regulation | 2020 |
[Preparation of evodiamine-glycyrrhizic acid micelles with glycyrrhizic acid as carrier and their anti-hepatic fibrosis activity].
Topics: Animals; Drug Carriers; Glycyrrhizic Acid; Liver Cirrhosis; Micelles; Particle Size; Quinazolines; Rats; Solubility | 2020 |
Caffeine Suppresses the Activation of Hepatic Stellate Cells cAMP-Independently by Antagonizing Adenosine Receptors.
Topics: Animals; Caffeine; Cells, Cultured; Chelating Agents; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Hepatic Stellate Cells; Liver Cirrhosis; Male; MAP Kinase Signaling System; Mice; Phosphodiesterase Inhibitors; Phosphorylation; Quinazolines; Receptors, Purinergic P1; Triazoles | 2017 |
Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy.
Topics: Biliary Atresia; Biomarkers; Biopsy, Needle; Case-Control Studies; Child, Preschool; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infant; Keratins; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Portoenterostomy, Hepatic; Quinazolines; Reoperation; Retrospective Studies; Risk Assessment; RNA; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Time Factors | 2017 |
Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease.
Topics: Animals; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; ErbB Receptors; Hepatic Stellate Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Quinazolines; Rats; Tyrphostins | 2018 |
Inhibition of Epidermal Growth Factor Receptor (EGFR) Reduces Lipopolysaccharide (LPS)-Induced Activation and Inflammatory Cytokines in Hepatic Stellate Cells In Vitro.
Topics: Animals; Cell Proliferation; Cell Survival; Cytokines; ErbB Receptors; Extracellular Matrix; Gene Knockdown Techniques; Genes, src; Hepatic Stellate Cells; Inflammation; Lipopolysaccharides; Liver; Liver Cirrhosis; Male; NF-kappa B; Primary Cell Culture; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Transforming Growth Factor beta; Tyrphostins | 2018 |
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Diethylnitrosamine; Disease Models, Animal; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Hepatic Stellate Cells; Hepatocytes; Humans; Ligation; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Phosphorylation; Prognosis; Quinazolines; Rats; Rats, Wistar; Transcriptome | 2014 |
Erlotinib might be a double-edged sword in HCC.
Topics: Animals; Carcinoma, Hepatocellular; Disease Progression; ErbB Receptors; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Quinazolines | 2015 |
Reply: To PMID 24677197.
Topics: Animals; Carcinoma, Hepatocellular; Disease Progression; ErbB Receptors; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Quinazolines | 2015 |
Gefitinib for non-small cell lung cancer patients with liver cirrhosis.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Liver Cirrhosis; Lung Neoplasms; Middle Aged; Point Mutation; Protein Kinase Inhibitors; Quinazolines | 2009 |
Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats.
Topics: Animals; Collagen Type I; Extracellular Matrix; Liver Cirrhosis; Liver Regeneration; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Thioacetamide | 2002 |
Clinical efficacy and toxiciy of gefitinib in patients with lung cancer.
Topics: Aged; Antineoplastic Agents; Ascites; Carcinoma, Non-Small-Cell Lung; Gefitinib; Hepatitis C, Chronic; Humans; Hypoalbuminemia; Liver Cirrhosis; Lung Diseases, Interstitial; Lung Neoplasms; Male; Quinazolines | 2003 |
[2 new non-mercurial oral diuretics: quinethazone and cyclopenthiazide].
Topics: Benzothiadiazines; Cyclopenthiazide; Diuretics; Edema; Heart Failure; Liver Cirrhosis; Quinazolines; Sulfonamides | 1963 |
QUINETHAZONE AS A DIURETIC AGENT.
Topics: Blood Protein Disorders; Diuretics; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Quinazolines; Sulfonamides | 1963 |
EVALUATION OF QUINETHAZONE, A NEW DIURETIC.
Topics: Ascites; Coronary Disease; Diuretics; Edema; Hypertension; Liver Cirrhosis; Quinazolines; Rheumatic Heart Disease; Sulfonamides | 1963 |
[CLINICAL STUDY OF A DIURETIC, QUINETHAZONE].
Topics: Anuria; Ascites; Blood Chemical Analysis; Diuretics; Edema; Liver Cirrhosis; Pharmacology; Quinazolines; Statistics as Topic; Sulfonamides; Toxicology | 1963 |
A CLINICAL TRIAL OF A NEW QUINAZOLINONE DIURETIC.
Topics: Coronary Disease; Diuretics; Edema; Humans; Liver Cirrhosis; Nephrotic Syndrome; Organomercury Compounds; Quinazolines; Quinazolinones; Sulfonamides | 1964 |
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Diethylnitrosamine; ErbB Receptors; Gefitinib; Liver Cirrhosis; Liver Neoplasms; Male; Quinazolines; Rats; Rats, Wistar; Signal Transduction; Transforming Growth Factor alpha | 2005 |
Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.
Topics: Animals; Cell Line; Cell Movement; Cell Proliferation; Cells, Cultured; Collagenases; Enzyme Induction; Hepatocytes; Liver Cirrhosis; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Piperidines; Quinazolines; Quinazolinones; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction | 2006 |
Prazosin protein binding in health and disease.
Topics: Adult; Blood Proteins; Erythrocytes; Female; Heart Failure; Humans; In Vitro Techniques; Kidney Failure, Chronic; Liver Cirrhosis; Male; Prazosin; Protein Binding; Quinazolines | 1980 |
Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
Topics: Animals; Cell Division; Liver; Liver Cirrhosis; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Thioacetamide | 2001 |
[Non-alcoholic steatohepatitis with cirrhosis after raltitrexed administration].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Disease Progression; Drug Monitoring; Fat Necrosis; Fatty Liver; Female; Humans; Liver Cirrhosis; Liver Function Tests; Middle Aged; Quinazolines; Rectal Neoplasms; Thiophenes; Thymidylate Synthase | 2001 |
Serum vitamin B12 levels in patients with primary hepatocellular carcinoma during treatment with CB3717.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Folic Acid; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Quinazolines; Vitamin B 12 | 1987 |
Clinical application of a new in vitro bleeding time device on surgical patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aspirin; Bleeding Time; Epoprostenol; Hemorrhage; Hemostasis; Humans; Liver Cirrhosis; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Quinazolines; Skin; Thrombocytopenia; Ticlopidine | 1988 |
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Topics: Ascites; Blood Urea Nitrogen; Creatinine; Diuretics; Edema; Furosemide; Humans; Injections, Intravenous; Kidney Diseases; Liver Cirrhosis; Natriuresis; Potassium; Protein Binding; Quinazolines; Sodium; Sulfonamides; Time Factors; Urea | 1973 |